Tech24 Deals Web Search

Search results

1. Results from the Tech24 Deals Content Network

2. Orlistat - Wikipedia

   en.wikipedia.org/wiki/Orlistat

   Orlistat, sold under the brand name Xenical among others, is a medication used to treat obesity. Its primary function is preventing the absorption of fats from the human diet by acting as a lipase inhibitor, thereby reducing caloric intake. It is intended for use in conjunction with a healthcare provider-supervised reduced-calorie diet.

3. Lipase inhibitors - Wikipedia

   en.wikipedia.org/wiki/Lipase_inhibitors

   Studies have shown that lipase inhibitors work optimally when 40% of an individual's daily caloric intake is obtained from fat. [1] [clarification needed] Orlistat tends to block absorption of 30% of total fat intake from a meal, as orlistat passes out of the digestive tract more rapidly than fat does. [2]

4. Discovery and development of gastrointestinal lipase ...

   en.wikipedia.org/wiki/Discovery_and_development...

   Cetilistat was developed to overcome the adverse effects on the gastrointestinal tract of orlistat. It has a different structure but similar inhibition activity to the gastrointestinal lipase. However cetilistat interacts differently with the fat micelles from digested food, therefore it has less side effects and better tolerability. [14]

5. Steatorrhea - Wikipedia

   en.wikipedia.org/wiki/Steatorrhea

   Steatorrhea. Specialty. Gastroenterology, general surgery. Steatorrhea (or steatorrhoea) is the presence of excess fat in feces. Stools may be bulky and difficult to flush, have a pale and oily appearance, and can be especially foul-smelling. [ 1] An oily anal leakage or some level of fecal incontinence may occur.

6. How a new FDA-approved drug can — and can’t — help people ...

   www.aol.com/lifestyle/fda-approved-drug-t-help...

   Leqembi’s side effects and other potential issues. Leqembi offers doctors the first new Alzheimer’s treatment option in years. But it also has some possibly dangerous side effects. Those ...

7. Lilly says weight loss drug cuts heart failure risk by 38% in ...

   www.aol.com/news/lilly-says-weight-loss-drug...

   By Deena Beasley (Reuters) -Trial results show Eli Lilly's weight loss drug Zepbound reduces the risk of hospitalization, death and other outcomes for obese adults with a common type of heart ...